(Circulation. 2001;103:2879.)
© 2001 American Heart Association, Inc.
Editorial |
From the Vascular Biology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md.
Correspondence to Elizabeth G. Nabel, MD, NHLBI/NIH, Bldg 10/8C 103, Bethesda, MD 20892. E-mail enabel@nih.gov
Key Words: Editorials cell cycle cyclins
Formation of a healed arterial wound is a landmark event during the repair of vascular lesions. Adult coronary, peripheral, and cerebral arteries are exposed to multiple stresses, including mechanical trauma, endothelial denudation, damage to intimal and medial smooth muscle, abnormal shear stresses, and oxidation of LDL by macrophages, and they must undergo repair. This wound repair process, like in many other organs, requires that a complex network of molecular signals be regulated within the cytoplasm and nucleus of an endothelial or smooth muscle cell. The cell cycle is a key regulator of these signals and has direct effects on multiple cell processes, including cell proliferation, DNA repair, apoptosis, and cell migration.
Vascular smooth muscle cells (VSMCs) within the media of
adult arteries are normally quiescent, proliferate at low indices, and
exist in the G0 phase of the cell cycle
(Figure 1
). On stimulation by growth factors or after
mechanical trauma, VSMCs exit the quiescent stage
G0 and progress through the
G1 and G1/S transition of
the cell cycle. G1 progression is regulated by
the assembly and phosphorylation of
G1 cyclin/cyclin-dependent kinase (CDK)
complexes, predominantly cyclin D/CDK-4,6 and cyclin E/CDK-2 in VSMCs.
For example, cyclin D is a growth factor sensor whose transcription
initiation, assembly, and nuclear transport is mitogen-dependent.
Endogenous inhibitors of the cyclin/CDK
complexes are termed the CDK inhibitors
(CKIs).1 Two groups of CKIs
are dominant in cardiovascular biology: the
CIP/KIP family, which includes
p21Cip1, p27Kip1,
and p57Kip2, and the INK4 family, which
includes
This article has been cited by other articles:
![]() |
C. Ruster, T. Bondeva, S. Franke, M. Forster, and G. Wolf Advanced glycation end-products induce cell cycle arrest and hypertrophy in podocytes Nephrol. Dial. Transplant., July 1, 2008; 23(7): 2179 - 2191. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Kundumani-Sridharan, D. Wang, M. Karpurapu, Z. Liu, C. Zhang, N. Dronadula, and G. N. Rao Suppression of Activation of Signal Transducer and Activator of Transcription-5B Signaling in the Vessel Wall Reduces Balloon Injury-Induced Neointima Formation Am. J. Pathol., October 1, 2007; 171(4): 1381 - 1394. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Costa and D. I. Simon Molecular Basis of Restenosis and Drug-Eluting Stents Circulation, May 3, 2005; 111(17): 2257 - 2273. [Full Text] [PDF] |
||||
![]() |
D. Torella, D. Leosco, C. Indolfi, A. Curcio, C. Coppola, G. M. Ellison, V. G. Russo, M. Torella, G. L. Volti, F. Rengo, et al. Aging exacerbates negative remodeling and impairs endothelial regeneration after balloon injury Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2850 - H2860. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Shimizu-Hirota, H. Sasamura, M. Kuroda, E. Kobayashi, M. Hayashi, and T. Saruta Extracellular Matrix Glycoprotein Biglycan Enhances Vascular Smooth Muscle Cell Proliferation and Migration Circ. Res., April 30, 2004; 94(8): 1067 - 1074. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gershlick, I. De Scheerder, B. Chevalier, A. Stephens-Lloyd, E. Camenzind, C. Vrints, N. Reifart, L. Missault, J.-J. Goy, J. A. Brinker, et al. Inhibition of Restenosis With a Paclitaxel-Eluting, Polymer-Free Coronary Stent: The European evaLUation of pacliTaxel Eluting Stent (ELUTES) Trial Circulation, February 3, 2004; 109(4): 487 - 493. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Potente, B. Fisslthaler, R. Busse, and I. Fleming 11,12-Epoxyeicosatrienoic Acid-induced Inhibition of FOXO Factors Promotes Endothelial Proliferation by Down-Regulating p27Kip1 J. Biol. Chem., August 8, 2003; 278(32): 29619 - 29625. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Bornfeldt The Cyclin-Dependent Kinase Pathway Moves Forward Circ. Res., March 7, 2003; 92(4): 345 - 347. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |